GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.
Our Work
Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.
Clinical Trial
Networks
Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more32 members
Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 32 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.
All membersLatest news
All newsCOVID-19: Advances and Remaining Challenges international conference opens September 29
22/09/2021Institut Pasteur will hold this international conference in collaboration with Inserm ANRS - Maladies infectieuses émergentes from September 29 to...
Read moreGloPID-R Scientific Advisory Group releases report with COVID-19 research priorities and recommendations
06/09/2021The key priorities identified in COVID-19 Research Recommendations & Considerations for GloPID-R, 2021-2023 will inform the global network’s coordinated approach...
Read moreThe power of tracking COVID-19 research funding in real time
25/08/2021In a Wellcome Open Research blog post, Dr. Alice Norton explains how the COVID-19 Project Tracker and associated Living Mapping...
Read moreResources
GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.
All resources